Home
IDM Pharma

IDM Pharma Market Share Analysis for June 2026

millennium develops and markets velcade (r) (bortezomib) for injection, a first-in-class cancer therapy for the treatment of patients with multiple myeloma and relapsed mantle cell lymphoma.

Industry: N/A

Domainidm-pharma.com

Year Founded--

Employees1001 - 5000

Annual Revenue$500M - $1B

IDM Pharma

IDM Pharma (including company regionals)

idm-pharma.com

See more website traffic and engagement information

IDM Pharma Revenue up to June 2026 is 500M - 1B

revenue generated by IDM Pharma top domains

IDM Pharma top domains revenue over 3 years

Revenue for IDM Pharma top domains

idm-pharma.com500M - 1B

See more with Sales Intelligence

Total visits to IDM Pharma's top domains

Understand IDM Pharma market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in IDM Pharma's top domains

Analyze IDM Pharma engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on IDM Pharma's top domains

See how IDM Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

IDM Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by IDM Pharma

These are the website technologies, by industry, used by IDM Pharma top domains

Email Services (1)

G Suite